187 related articles for article (PubMed ID: 18202794)
1. Phase I study of weekly topotecan combined to concurrent external cranial irradiation in adults with glioblastoma multiforme of the brain.
Varveris H; Petinelli E; Stratakis J; Mazonakis M
Oncol Rep; 2008 Feb; 19(2):447-55. PubMed ID: 18202794
[TBL] [Abstract][Full Text] [Related]
2. Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: results of Radiation Therapy Oncology Group Trial 9507.
Fisher BJ; Scott C; Macdonald DR; Coughlin C; Curran WJ
J Clin Oncol; 2001 Feb; 19(4):1111-7. PubMed ID: 11181676
[TBL] [Abstract][Full Text] [Related]
3. Phase I study of topotecan in combination with concurrent radiotherapy in adults with glioblastoma.
Lesimple T; Hassel MB; Gédouin D; Seigneuret E; Carsin B; Hamlat A; Riffaud L; Simon H; Malhaire JP; Guégan Y
J Neurooncol; 2003 Nov; 65(2):141-8. PubMed ID: 14686734
[TBL] [Abstract][Full Text] [Related]
4. Acute toxicity and changes in quality of life during a combined radio-chemotherapy of glioblastomas with topotecan (Hycamtin).
Gross MW; Altscher R; Brandtner M; Häusser-Mischlich H; Kiricuta IC; Siegmann AD; Engenhart-Cabillic R
Strahlenther Onkol; 2001 Dec; 177(12):656-61. PubMed ID: 11789404
[TBL] [Abstract][Full Text] [Related]
5. Open-label simultaneous radio-chemotherapy of glioblastoma multiforme with topotecan in adults.
Gross MW; Altscher R; Brandtner M; Haeusser-Mischlich H; Chiricuta IC; Siegmann AD; Engenhart-Cabillic R
Clin Neurol Neurosurg; 2005 Apr; 107(3):207-13. PubMed ID: 15823676
[TBL] [Abstract][Full Text] [Related]
6. Phase I/II trial of simultaneous whole-brain irradiation and dose-escalating topotecan for brain metastases.
Kocher M; Eich HT; Semrau R; Güner SA; Müller RP
Strahlenther Onkol; 2005 Jan; 181(1):20-5. PubMed ID: 15660189
[TBL] [Abstract][Full Text] [Related]
7. Concurrent chemoradiotherapy and adjuvant chemotherapy with Topotecan for patients with glioblastoma multiforme.
Klautke G; Schütze M; Bombor I; Benecke R; Piek J; Fietkau R
J Neurooncol; 2006 Apr; 77(2):199-205. PubMed ID: 16314953
[TBL] [Abstract][Full Text] [Related]
8. Prolonged infusional topotecan and accelerated hyperfractionated 3d-conformal radiation in patients with newly diagnosed glioblastoma--a phase I study.
Grabenbauer GG; Anders K; Fietkau RJ; Klautke G; Feldmann HJ; Weiser S; Staab HJ; Krauseneck P; Sauer R
J Neurooncol; 2002 Dec; 60(3):269-75. PubMed ID: 12510778
[TBL] [Abstract][Full Text] [Related]
9. A phase I clinical trial of weekly oral topotecan for relapsed small cell lung cancer.
Agelaki S; Kontopodis E; Kotsakis A; Chandrinos V; Bompolaki I; Zafeiriou Z; Papadimitraki E; Stoltidis D; Kalbakis K; Georgoulias V
Cancer Chemother Pharmacol; 2013 Jul; 72(1):45-51. PubMed ID: 23604531
[TBL] [Abstract][Full Text] [Related]
10. Phase I clinical trial assessing temozolomide and tamoxifen with concomitant radiotherapy for treatment of high-grade glioma.
Patel S; DiBiase S; Meisenberg B; Flannery T; Patel A; Dhople A; Cheston S; Amin P
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):739-42. PubMed ID: 21353747
[TBL] [Abstract][Full Text] [Related]
11. A phase I clinical trial of topotecan given every 2 weeks in patients with refractory solid tumors.
Kakolyris S; Kouroussis C; Souglakos J; Mavroudis D; Agelaki S; Kalbakis K; Androulakis N; Vardakis N; Vamvakas L; Georgoulias V
Oncology; 2001; 61(4):265-70. PubMed ID: 11721172
[TBL] [Abstract][Full Text] [Related]
12. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
Choi NC; Herndon JE; Rosenman J; Carey RW; Chung CT; Bernard S; Leone L; Seagren S; Green M
J Clin Oncol; 1998 Nov; 16(11):3528-36. PubMed ID: 9817271
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of topotecan plus cranial radiation for glioblastoma multiforme: results of Radiation Therapy Oncology Group 9513.
Fisher B; Won M; Macdonald D; Johnson DW; Roa W
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):980-6. PubMed ID: 12095566
[TBL] [Abstract][Full Text] [Related]
14. Phase I trial of continuous infusion 9-aminocamptothecin in patients with advanced solid tumors: 21-day infusion is an active well-tolerated regimen.
Sewak S; Sorich J; O'Leary J
Anticancer Drugs; 2006 Jun; 17(5):571-9. PubMed ID: 16702815
[TBL] [Abstract][Full Text] [Related]
15. A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.
Mok TS; Wong H; Zee B; Yu KH; Leung TW; Lee TW; Yim A; Chan AT; Yeo W; Chak K; Johnson P
Cancer; 2002 Oct; 95(7):1511-9. PubMed ID: 12237920
[TBL] [Abstract][Full Text] [Related]
16. Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors.
Gerrits CJ; Burris H; Schellens JH; Eckardt JR; Planting AS; van der Burg ME; Rodriguez GI; Loos WJ; van Beurden V; Hudson I; Fields S; Von Hoff DD; Verweij J
Clin Cancer Res; 1998 May; 4(5):1153-8. PubMed ID: 9607572
[TBL] [Abstract][Full Text] [Related]
17. Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: a Cancer and LeukemiaGroup B study.
Lilenbaum RC; Miller AA; Batist G; Bernard S; Hollis DR; Rosner GL; Egorin MJ; Schilsky RL; Ratain MJ
J Clin Oncol; 1998 Oct; 16(10):3302-9. PubMed ID: 9779705
[TBL] [Abstract][Full Text] [Related]
18. Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study.
Hochster H; Liebes L; Speyer J; Sorich J; Taubes B; Oratz R; Wernz J; Chachoua A; Blum RH; Zeleniuch-Jacquotte A
Clin Cancer Res; 1997 Aug; 3(8):1245-52. PubMed ID: 9815806
[TBL] [Abstract][Full Text] [Related]
19. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
[TBL] [Abstract][Full Text] [Related]
20. Topotecan in combination with radiotherapy in unresectable glioblastoma: a phase 2 study.
Lesimple T; Riffaud L; Frappaz D; Ben Hassel M; Gédouin D; Bay JO; Linassier C; Hamlat A; Piot G; Fabbro M; Saïkali S; Carsin B; Guégan Y
J Neurooncol; 2009 Jun; 93(2):253-60. PubMed ID: 19139825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
